This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Tvardi Operating Company, Inc., Tvardi Therapeutics, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Brad Henke: Innovator in Pharmaceutical Development
Introduction
Brad Henke is a notable inventor based in Cary, NC (US), recognized for his contributions to the field of pharmaceuticals. He holds 2 patents that focus on innovative treatments for serious health conditions.
Latest Patents
Henke's latest patents include advancements in prodrugs of STAT3 inhibitors. These compounds are designed to treat various diseases and disorders, including cancer, fibrosis, and chronic inflammation. The patents detail specific compounds of Formula I, along with their pharmaceutically acceptable salts or solvates, and their potential therapeutic uses.
Career Highlights
Throughout his career, Brad Henke has worked with prominent companies in the pharmaceutical industry, including Tvardi Operating Company, Inc. and Tvardi Therapeutics, Inc. His work has significantly contributed to the development of new therapeutic options for patients.
Collaborations
Henke has collaborated with talented professionals in his field, including Imran Alibhai and Sofia De Achaval. These partnerships have fostered innovation and advancement in pharmaceutical research.
Conclusion
Brad Henke's work in developing prodrugs of STAT3 inhibitors showcases his commitment to improving healthcare through innovative solutions. His contributions are paving the way for new treatments that can make a difference in the lives of many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile